| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/25/2008 | CN101204542A Chinese traditional medicine prescripton for raising blood pressure and preparation method thereof |
| 06/25/2008 | CN101204535A Decoction medicine for retention of phlegmatic dampness hypertension |
| 06/25/2008 | CN101204522A Pharmaceutical capsules for blood deficiency hypertension |
| 06/25/2008 | CN101204503A Composite of Panax notoginseng and rhizoma anemarphenae extractive |
| 06/25/2008 | CN101204502A Application of anti-atherosclerosis Chinese traditional medicine and fistular onion stalk extractive on curing atherosclerosis |
| 06/25/2008 | CN101204460A Preparation for varicocele |
| 06/25/2008 | CN101204459A Compound notoginseng removing obstruction from collaterals pill |
| 06/25/2008 | CN101204455A Chinese traditional medicine preparation for curing varicocele |
| 06/25/2008 | CN101204440A Medicine for varicosity |
| 06/25/2008 | CN101204438A Application of potentilla anseriana extractive on preparating anti-ischemic |
| 06/25/2008 | CN101204434A Quality standard for thrombus dispelling pill and test method thereof |
| 06/25/2008 | CN101204430A Extractive of total peony ladves glucoside, preparation method and uses thereof |
| 06/25/2008 | CN101204402A Vacuum freezing and drying technology for leech |
| 06/25/2008 | CN101204392A Self-emulsifying microemulsion daidzein oral liquid preparation composite and preparation method thereof |
| 06/25/2008 | CN101204391A Isoflavone compound curing atherosclerosis through strengthening reverse cholesterol transport mechanism and composite thereof |
| 06/25/2008 | CN101204372A Cinepazide maleate injection and preparation method thereof |
| 06/25/2008 | CN101204216A Coffee partner containing octacosanol and manufacture method thereof |
| 06/25/2008 | CN101204210A Buckwheat-boiled noodle and manufacture method thereof |
| 06/25/2008 | CN101204180A Ju-Huai Tea beverage and its manufacture method |
| 06/25/2008 | CN101204179A Antihypertensive beverage and manufacture method |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/25/2008 | CN100396677C 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 06/25/2008 | CN100396668C Non-imidazole aryloxypiperidines |
| 06/25/2008 | CN100396665C Pyrrolidine derivative, preparation method thereof and pharmaceutical composition containing the compound |
| 06/25/2008 | CN100396330C Composition and method for repairing nerve damage and enhancing functional recovery of nerve |
| 06/25/2008 | CN100396298C New technology for refining xiasanju extract using membrane separation technique |
| 06/25/2008 | CN100396297C Composition of Chinese traditional medicine for treating cardiovascular diseases |
| 06/25/2008 | CN100396291C Injection of calf blood de-protein extract and preparation method thereof |
| 06/25/2008 | CN100396286C Use of homoharringtonine and harringtonine in inhibiting vascularization |
| 06/25/2008 | CN100396284C Novel galneical form for oral administration with prolonged release of molsidomine |
| 06/25/2008 | CN100396282C Slow released doxazosin mesilate capsule and its preparation process |
| 06/25/2008 | CN100396279C Chinese medicinal preparation for treating arrhythmia and its preparation method |
| 06/24/2008 | US7390924 Terphenyl derivatives, preparation thereof, compositions containing same |
| 06/24/2008 | US7390905 Tachykinin receptor antagonists for use treating e.g. emesis, depression, urinary disorder |
| 06/24/2008 | US7390885 Humanized collagen antibodies and related methods |
| 06/24/2008 | US7390822 Delta-2 opioid receptor agonists; protecting cardiac and cerebral organs |
| 06/24/2008 | US7390821 Administering nicotinic acetylcholine receptor antagonist; ocular diseases; monoclonal antibodies |
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/24/2008 | US7390812 N, N'-disubstituted piperazine compounds and their use as analgesics |
| 06/24/2008 | US7390809 7-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-2-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[1,5- alpha ]pyrazine, hydrochloride; antidiabetic agent, non-insulin dependent diabetes; synergistic mixture with other active ingredients |
| 06/24/2008 | US7390808 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes |
| 06/24/2008 | US7390797 Fused indazole compounds |
| 06/24/2008 | US7390790 Antilipemic agents; anticholesterol agents, for example, 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-yl]benzylcarbamoyl}phenoxy)benzoic acid |
| 06/24/2008 | US7390783 Charged phospholipid compositions and methods for their use |
| 06/24/2008 | US7390668 Halogenated xanthan compound |
| 06/24/2008 | US7390634 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation |
| 06/24/2008 | US7390633 Methods for preparing low molecular weight heparin with modified heparinase III |
| 06/24/2008 | US7390630 Method of identifying a compound that selectively inhibits cytokine-stimulated T cell induced production of TNF-alpha by monocytes |
| 06/24/2008 | US7390625 Apoptosis-associated protein and use thereof |
| 06/24/2008 | US7390519 Probiotic Lactobacillus salivarius strains |
| 06/24/2008 | US7390484 Self-contained adipose derived stem cell processing unit |
| 06/19/2008 | WO2008074001A1 Renin inhibitors for the prevention and treatment of hypertension in obese patients |
| 06/19/2008 | WO2008073958A2 Substituted benzothiadiazinedioxide derivatives and methods of their use |
| 06/19/2008 | WO2008073936A1 Carboxamide derivatives as ion channel modulators |
| 06/19/2008 | WO2008073934A1 Ion channel modulators |
| 06/19/2008 | WO2008073929A1 Ion channel modulators |
| 06/19/2008 | WO2008073928A1 Composition for treating a pulmonary hypertension |
| 06/19/2008 | WO2008073927A1 Ambrisentan combined with a renin inhibitor for hypertensive disorder |
| 06/19/2008 | WO2008073865A2 Method of preventing or treating myocardial ischemia |
| 06/19/2008 | WO2008073623A2 Soluble epoxide hydrolase inhibitors |
| 06/19/2008 | WO2008073461A2 Ion channel modulators |
| 06/19/2008 | WO2008073395A2 Compositions and methods for cardiac tissue protection and regeneration |
| 06/19/2008 | WO2008073392A2 Compositions and methods for cardiac tissue protection and regeneration |
| 06/19/2008 | WO2008073318A2 Use of atp in controlled regional reperfusion as treatment during acute myocardial infarction |
| 06/19/2008 | WO2008072779A1 Quinoxaline derivative |
| 06/19/2008 | WO2008072726A1 1-phenyl 1-thio-d-glucitol derivative |
| 06/19/2008 | WO2008072725A1 Composition containing agaricus blazei murill |
| 06/19/2008 | WO2008072682A1 Imidazo[1,2-b]pyridazine derivative |
| 06/19/2008 | WO2008072190A2 Compositions of azimilide dihydrochloride |
| 06/19/2008 | WO2008071738A1 Selective inhibitors of neurotensin degrading enzymes |
| 06/19/2008 | WO2008071081A1 Preparation of low bleeding anticoagulant fusion protein and its use |
| 06/19/2008 | WO2008070995A1 Methods and treatments for prevention of acute renal failure following cardiac surgery |
| 06/19/2008 | WO2008070948A1 Extracts from the skin of fruits of plants from genus vitis, compositions containing the same and a process for its manufacture |
| 06/19/2008 | WO2008051875A3 Adamantylurea compounds as soluble epoxide hydrolase inhibitors |
| 06/19/2008 | WO2008051873A3 Phenylurea compounds as soluble epoxide hydrolase inhibitors |
| 06/19/2008 | WO2008049996A3 Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 06/19/2008 | WO2008045566B1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 06/19/2008 | WO2008044217A3 2-aminocarbonyl-pyridine derivatives |
| 06/19/2008 | WO2007121447A3 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 06/19/2008 | US20080146812 Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias |
| 06/19/2008 | US20080146673 Pentafluorosulfanylbenzoylguanidines, process for their preparation, use as a medicament or diagnostic aid, and medicament comprising same |
| 06/19/2008 | US20080146671 Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amide renin inhibitor in absorption enhancing carrier comprising lipophilic component, high HLB surfactant, hydrophilic component, which on mixing forms stable microemulsion concentrate; bioavailability; side effect reduction; cardiovascular disorders |
| 06/19/2008 | US20080146668 Method for stimulating weight loss and/or for lowering triglycerides in patients |
| 06/19/2008 | US20080146665 Synergistically Heat Stable Oil Media Having Eicosa Pentanoic Acid (Epa) and Docosa Hexaenoic Acid (Dha) |
| 06/19/2008 | US20080146663 Derivatives of 11-nonyloxy-undec-8(Z)-eonic acid, e.g., (Z)-1,3-dihydroxypropan-2-yl 11-(nonyloxy)undec-8-enoate; compounds mimic epoxide metabolites; for use in treatment of renal or cardiovascular disease; hypotensive agents |
| 06/19/2008 | US20080146644 Tricyclic Cytoprotective Compounds |
| 06/19/2008 | US20080146639 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment |
| 06/19/2008 | US20080146631 Peroxisome proliferator activated receptor modulators; diabetes mellitus; side effects reduction; 2-Methyl-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenoxy}propionic acid; Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis |
| 06/19/2008 | US20080146630 Estrogen receptor modulators; neurodegenerative disorders; cognitive enhancement |
| 06/19/2008 | US20080146620 Dibenzylamine Compounds and Pharmaceutical Use Thereof |
| 06/19/2008 | US20080146614 Therapeutic Agents |
| 06/19/2008 | US20080146612 Novel Biaromatic Compounds, Inhibitors of the P2X7-Receptor |
| 06/19/2008 | US20080146604 adenosine receptor antagonists such as 2-(4-Methoxyphenyl)-9-benzylamino-10-cyano-s-triazolo[1,5-a]quinolin, used for treating respiratory system disorders, vision disorders, tumors, allergies or inflammatory disease, ischemia, hypoxia, arrhythmia or urogential disorders |
| 06/19/2008 | US20080146599 receptor tyrosine kinase inhibitors such as 2-chloro-N-{3-[(4,6-diaminopyrimidin-5-yl)ethynyl]phenyl}benzenesulfonamide, used as angiogenesis inhibitors in mammals |
| 06/19/2008 | US20080146575 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one as crystalline; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic with BRCA2 deficient phenotype; septic shock, ischemic injury, multiple sclerosis |
| 06/19/2008 | US20080146566 treatment of diseases mediated by cytokines; N-cyclopropyl-4-methyl-3-(1-oxoisoquinolin-2(1H)-yl)benzamide; rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease, multiple sclerosis, AIDS, septic shock, congestive heart failure, ischaemic heart disease, psoriasis |
| 06/19/2008 | US20080146543 Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats |
| 06/19/2008 | US20080146534 Pharmaceutical composition for reducing the risks associated with cardiovascular and cerebrovascular diseases |
| 06/19/2008 | US20080146533 Containing tertiary amine linked pyrrolidine, azetidine, morpholine or piperidine group; inhibiting GlyCer synthase, lowering glycosphingolipid levels; collagen vascular diseases, atherosclerosis, diabetic renal hypertrophy |
| 06/19/2008 | US20080146524 Such as 3-[Hydroxy-(3-phenyl-butyl)-phosphinoyl]-propionyl)-2-amino-(3-methyl-butyrylamino)hexcanoic acid; intermediates; potent and selective endopeptidases inhibitors |